Takeover
Commented by Armin Schulz on November 18th, 2025 | 07:05 CET
Patents, potential, takeover candidate? Making money with less risk: The secret of BioNxt Solutions
In the high-risk world of biotechnology, the path from the laboratory to an approved drug is often an ordeal. Canadian company BioNxt Solutions may have found the key to a less painful path. Instead of developing expensive and uncertain new active ingredients, the Company refines proven drugs with innovative administration technology. The past few months have brought a remarkable series of successes that not only confirm the technology but also significantly increase the strategic value of the Company. For investors, this could be a rare opportunity.
Read
Commented by Nico Popp on November 17th, 2025 | 07:05 CET
Takeover fever among juniors: Formation Metals, Barrick Mining, and Gold Fields
The price of gold has reached new record highs this year, climbing above USD 4,000 per ounce. This rally is increasingly attracting new groups of investors - not only institutional players but also private investors who until recently focused mainly on tech stocks. In this environment, junior mining companies with promising projects are moving sharply into the spotlight. These juniors, smaller exploration companies without their own production, are widely regarded as the key discoverers of new deposits. In fact, according to asset manager VanEck, between 60 and 70% of all significant gold discoveries originate from junior explorers. Sufficiently capitalized juniors with promising deposits are therefore in strong demand. They offer established producers an efficient way to replenish reserves without carrying out years of costly exploration themselves. One example of such a company is Formation Metals.
Read
Commented by Fabian Lorenz on November 14th, 2025 | 07:15 CET
AI fantasy, takeover rumors, and a 14% dividend: TKMS, TeamViewer, RE Royalties
Investors can currently expect a 14% dividend yield when buying RE Royalties shares. In addition, the price seems far too low. After all, the Company is increasingly financing renewable energy projects in the US, and the market is booming due to the energy hunger of AI data centers. TeamViewer's stock has not boomed for quite some time. Even after the price halved, the stock has not found a bottom. Can AI fantasy cause investors to rethink their position? TKMS has recently held up well in the sell-off of defense stocks. Now there are takeover rumors. Accordingly, the stock market newcomer is about to take over its neighboring shipyard.
Read
Commented by Fabian Lorenz on November 12th, 2025 | 06:55 CET
Caution with Plug Power and Gerresheimer! Gold heading toward USD 10,000? What is happening with Formation Metals shares?
Experts see Formation Metals as a potential multi-million-ounce gold story with takeover potential. In addition, the Canadian exploration company's cash position is almost equal to its market capitalization. In contrast, Plug Power's cash burn remains high. Will the stock market be satisfied with the reduction in losses and speculation around AI and energy? And what is Gerresheimer doing? The stock's decline appears to be relentless, with personnel changes having little effect so far. Meanwhile, a drop below the EUR 20 mark is also possible.
Read
Commented by Fabian Lorenz on November 5th, 2025 | 07:10 CET
Millions for BioNTech and Evotec! But drug development is costly! Is NetraMark the next takeover target?
NetraMark scores again. The Company's AI has convinced yet another biopharma company and is increasingly shaping up as a potential takeover target. The new client will use NetraAI to optimize its clinical trial, cutting both time and costs. The high expense of drug development is clear: BioNTech invested EUR 565 million into its pipeline last quarter. However, the German biotech leader can afford this thanks to billions in its coffers. Analysts still recommend buying the stock. By contrast, even a million-dollar payment from a partner could not give Evotec shares any real momentum. Could today’s figures finally spark a turnaround?
Read
Commented by Fabian Lorenz on October 28th, 2025 | 07:00 CET
A MAJOR DEVELOPMENT IN GOLD! Will Newmont acquire Barrick Mining? Formation Metals and RENK also in focus!
This would be a major shake-up in the gold sector: Could Newmont acquire its longtime rival, Barrick Mining? Media reports suggest that this option is under consideration. Newmont is reported to have its sights set on the joint venture in the US state of Nevada. If the takeover actually goes ahead, it could be the start of a wave of acquisitions in the sector. Among the explorers, Formation Metals is an exciting candidate. The stock reacted yesterday with a jump in price following a successful capital raise. The CEO considers a resource expansion of up to 5 million ounces possible. Beyond gold, defense stocks are also consolidating. Analysts see further downside potential for RENK. Could the share price fall below EUR 60?
Read
Commented by Fabian Lorenz on October 14th, 2025 | 07:30 CEST
Alternative to BioNTech, Evotec, and Co.: BioNxt Solutions impresses at investor conference and sparks takeover speculation
While the shares of BioNTech and Evotec are treading water, BioNxt Solutions is on an upward trajectory. The Company is currently shaking up Big Pharma. The announcement to replace the weight-loss injection Ozempic with an oral dissolvable film has sparked takeover speculation. BioNxt also aims to make waves in multiple sclerosis, another multi-billion-dollar market, by significantly simplifying the administration of a blockbuster drug for patients. At last week's IIF investor conference, the management board delivered a convincing presentation. Partnerships and licensing opportunities were outlined - assuming no acquisition occurs beforehand. This could prove highly rewarding for both a pharmaceutical company and shareholders.
Read
Commented by Fabian Lorenz on September 15th, 2025 | 07:20 CEST
Gold mining stocks in takeover fever! Barrick Mining and Newmont are selling! B2Gold neighbor Desert Gold in the crosshairs?
Takeover fever is sweeping through the gold sector. The typical cycle of the industry appears to be repeating itself once again: with the rising price of gold, which remains solidly above USD 3,600, the appetite for takeovers is also growing. Gold producers are earning more, and banks and private equity firms are opening their coffers for mergers and acquisitions. For large and small mining companies alike, the current market phase offers an opportunity to expand their portfolios, optimize projects, or reposition themselves through strategic sales and purchases. Barrick and Newmont are currently raising billions through asset sales, boosting their war chests. In contrast, Desert Gold - a neighbor of B2Gold - could soon see a partner come on board or even become an acquisition target. Analysts see significant upside potential for the share.
Read
Commented by Fabian Lorenz on September 9th, 2025 | 07:20 CEST
Takeover candidate! Novo Nordisk and Eli Lilly eyeing BioNxt Solutions
A portfolio rocket for the coming weeks? The shares of BioNxt Solutions are certainly worth a closer look. There was no sign of a summer slump at this company - quite the opposite, as one major announcement followed another, and the newsflow continues into September. The Canadian-German life sciences company specializes in innovative drug delivery technologies. The latest bombshell: BioNxt aims to replace the Ozempic weight-loss injection with a tablet-like oral form of administration. This move opens the door to another billion-dollar market and positions the Company as a takeover candidate. Novo Nordisk, Eli Lilly, and others are engaged in fierce competition and are hungry for innovations – like those developed by BioNxt. The stock remains attractively priced.
Read
Commented by Fabian Lorenz on July 23rd, 2025 | 07:10 CEST
TAKEOVER SPECULATION! Barrick Mining, Evotec, Desert Gold
Just like the high prices, takeover speculation in the gold sector is also continuing. Desert Gold is repeatedly mentioned as a candidate. With its exciting acquisition in West Africa, the explorer has diversified and made itself even more attractive to a large corporation. Perhaps Barrick? The heavyweight is currently focusing on its ore mines and selling smaller projects. It could then expand again in the gold sector, and Desert certainly fits in regionally. In the biotech sector, Evotec has long been rumored as a takeover candidate. Following the latest revenue warning, this is likely the only hope for investors to achieve short-term returns. Or was the price slide exaggerated?
Read